Circulating endothelial progenitor cells in HIV infection: A systematic review

Trends in Cardiovascular Medicine - Tập 23 - Trang 192-200 - 2013
Cecilia T. Costiniuk1,2, Benjamin M. Hibbert2,3, Trevor Simard3, Feras M. Ghazawi2,4, Jonathan B. Angel1,2,4, Edward R. O’Brien5
1Division of Infectious Diseases, University of Ottawa, Ottawa, Canada
2Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada
3Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Canada
4Ottawa Hospital Research Institute, Ottawa, Canada
5Libin Cardiovascular Institute of Alberta and the University of Calgary, Foothills Medical Centre, Calgary, Alberta, Canada

Tài liệu tham khảo

Asahara, 1997, Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275, 964, 10.1126/science.275.5302.964 Assmus, 2006, Transcoronary transplantation of progenitor cells after myocardial infarction, New England Journal of Medicine, 355, 1222, 10.1056/NEJMoa051779 Cardinale, 2012, Nicotine: specific role in angiogenesis, proliferation and apoptosis, Critical Reviews in Toxicology, 42, 68, 10.3109/10408444.2011.623150 Corada, 1999, Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo, Proceedings of the National Academy of Sciences of the United States of America, 96, 9815, 10.1073/pnas.96.17.9815 Costiniuk, 2012, Endothelial progenitor cells are not reduced in HIV-infected men, Journal of Infectious Diseases, 205, 713, 10.1093/infdis/jir836 Cruciani, 2011, Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data, AIDS, 25, 1993, 10.1097/QAD.0b013e328349c6ee Currier, 2008, Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy, Circulation, 118, e29, 10.1161/CIRCULATIONAHA.107.189624 DAD Study Group, 2007, Class of antiretroviral drugs and the risk of myocardial infarction, New England Journal of Medicine, 356, 1723, 10.1056/NEJMoa062744 Da Silva, 2011, Imbalance between endothelial progenitor cells and microparticles in HIV-infected patients naïve for antiretroviral therapy, AIDS, 25, 1595, 10.1097/QAD.0b013e32834980f4 Dejana, 2004, Endothelial cell–cell junctions: happy together, Nature Reviews Molecular Cell Biology, 5, 261, 10.1038/nrm1357 Fadini, 2012, Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use, Circulation Research, 110, 624, 10.1161/CIRCRESAHA.111.243386 Fadini, 2008, Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens, Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 997, 10.1161/ATVBAHA.107.159558 George, 2003, Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis, Arteriosclerosis, Thrombosis, and Vascular Biology, 23, e57, 10.1161/01.ATV.0000107029.65274.db Gomez-Garre, 2012, Association of HIV-infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosis, Journal of Acquired Immune Deficiency Syndromes, 10.1097/QAI.0b013e31826afbfc Hibbert, 2009, Inhibition of endothelial progenitor cell glycogen synthase kinase-3beta results in attenuated neointima formation and enhanced re-endothelialization after arterial injury, Cardiovascular Research, 83, 16, 10.1093/cvr/cvp156 Hill, 2003, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk, New England Journal of Medicine, 348, 593, 10.1056/NEJMoa022287 Hirschi, 2008, Assessing the identity, phenotype and fate of endothelial progenitor cells, Arteriosclerosis, Thrombosis, and Vascular Biology, 28, 1584, 10.1161/ATVBAHA.107.155960 Hsue, 2012, Immunologic basis of cardiovascular disease in HIV-infected adults, Journal of Infectious Diseases, 205, S375, 10.1093/infdis/jis200 Lopez-Novoa, 2010, The physiological role of endoglin in the cardiovascular system, American Journal of Physiology—Heart and Circulatory Physiology, 299, H959, 10.1152/ajpheart.01251.2009 Lopez, 2011, High risk of endothelial dysfunction in HIV individuals may result in dysregulation of circulating endothelial cells and endothelial progenitor cells, AIDS Research and Human Retroviruses, 27, 1 Papasavvas, 2012, Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects, Antiviral Therapy, 17, 557, 10.3851/IMP2013 Pourdjabbar, 2011, Pathogenesis of neointima formation following vascular injury, Cardiovascular & Hematological Disorders—Drug Targets, 11, 30, 10.2174/187152911795945169 Puls, 2011, Effect of smoking cessation on the number and adhesive properties of early outgrowth endothelial progenitor cells, International Journal of Cardiology, 152, 61, 10.1016/j.ijcard.2010.07.007 Ren, 2009, Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection, American Journal of Cardiology, 104, 216, 10.1016/j.amjcard.2009.03.036 Ruifrok, 2009, Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia, Vascular Medicine, 14, 29, 10.1177/1358863X08096666 Sabin, 2008, Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multicohort collaboration, Lancet, 371, 1417, 10.1016/S0140-6736(08)60423-7 Schachinger, 2006, Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction, New England Journal of Medicine, 355, 1210, 10.1056/NEJMoa060186 Schmidt-Lucke, 2010, Quanitification of circulating endothelial progenitor cells using the modified ISHAGE protocol, PLoS One, 5, e13790, 10.1371/journal.pone.0013790 Schmidt-Lucke, 2005, Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endovascular repair, Circulation, 111, 2981, 10.1161/CIRCULATIONAHA.104.504340 Sen, 2012, Recent developments of regarding human immunodeficiency virus infection and stroke, Cerebrovascular Diseases, 33, 209, 10.1159/000335300 Strategies for the Management of Antiretroviral Therapy (SMART) Study Group, 2006, CD4+ count-guided interruption of antiretroviral treatment, New England Journal of Medicine, 355, 2283, 10.1056/NEJMoa062360 Sutherland, 1996, The ISHAGE guidelines for CD34+ cell determination by flow cytometry, Journal of Hematotherapy, 5, 213, 10.1089/scd.1.1996.5.213 Teofili, 2010, Endothelial progenitor cell trafficking in human immunodeficiency virus-infected person, AIDS, 24, 2443, 10.1097/QAD.0b013e32833ef79d Thorin, 2011, Vascular disease risk in patients with hypertriglyceridemia: endothelial progenitor cells, oxidative stress, accelerated senescence, and impaired vascular repair, Canadian Journal of Cardiology, 127, 538, 10.1016/j.cjca.2011.03.014 Urbich, 2004, Endothelial progenitor cells: characterization and role in vascular biology, Circulation Research, 95, 343, 10.1161/01.RES.0000137877.89448.78 Vasa, 2001, Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease, Circulation Research, 89, e1, 10.1161/hh1301.093953 Vittecoq, 2003, Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era, AIDS, 17, S70, 10.1097/00002030-200304001-00010 Werner, 2005, Circulating endothelial progenitor cells and cardiovascular outcomes, New England Journal of Medicine, 353, 999, 10.1056/NEJMoa043814 Zhong, 2002, HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells, Arteriosclerosis, Thrombosis, and Vascular Biology, 22, 1560, 10.1161/01.ATV.0000034707.40046.02